MIG 400mg x 20 tablets

Mig 400 mg 20 film-coated tablets

Name of the medicinal product MIG, 400 mg, film-coated tablets.

Qualitative and quantitative composition. One film-coated tablet contains 400 mg of ibuprofen (Ibuprofenum).

Pharmaceutical form. Coated tablets. White or almost white, oblong film-coated tablets with a dividing groove on both sides, marked on one side with the letters "E" on both sides of the dividing groove. The tablet can be divided into equal doses.

Indications for use of Mig 400

Symptomatic treatment: pain of mild to moderate intensity, fever.

Dosage of Mig 400

The recommended dose is:

After taking the maximum single dose, the next dose should be taken no sooner than 6 hours later.

The elderly and patients with a history of gastric and/or duodenal ulceration:

These patients should start treatment with the lowest dose (see section, 2: "Warnings and Precautions").

Renal or hepatic impairment:
In mild to moderate renal or hepatic impairment, dose reduction is not required.

Use in children and adolescents
If it becomes necessary to administer this product for more than 3 days in children over 6 years of age and adolescents, or if the symptoms present worsen, then consult a doctor.

Method and route of administration

For oral administration.
The film-coated tablets should be swallowed whole with a large amount of liquid (such as a glass of water) during or after a meal.

Information on tablet splitting:
The tablet can be divided into equal doses.

Holding the tablet with the index fingers and thumb of both hands so that the dividing groove falls on the bottom of the tablet, break the tablet in half along the dividing groove by pressing with the thumbs.

Treatment time

The drug is intended for short-term use only.

Do not use the drug without consulting a doctor if the presenting symptoms persist for more than 3 days in children and adolescents and in adults after 3 days of treatment of fever and after 4 days of treatment of pain.

If you feel that the effect of the drug is too strong or too weak, consult a doctor.

Using more than the recommended dose of MIG drug

Take MIG according to your doctor's instructions or the dosage instructions in the leaflet. If the pain-reducing effect seems too weak, do not increase the dose without consulting your doctor.

Symptoms of overdose may include:

• central nervous system disorders such as headache, dizziness and loss of consciousness (in children also seizures);
• gastrointestinal disorders such as abdominal pain, nausea and vomiting, gastrointestinal bleeding;
• renal and hepatic disorders;
• sudden decrease in blood pressure;
• respiratory disorders (respiratory collapse); bluish-red
• coloration of the skin and mucous membranes (cyanosis).

No specific antidote.

If an overdose of MIG drug is suspected, a doctor should be notified immediately. Depending on the degree of intoxication, the doctor will decide on further treatment.

If you forget to take MIG
Do not use a double dose to make up for a missed dose.

If you have any additional questions about the use of the drug, ask your doctor or pharmacist.

Contraindications of Mig 400

Hypersensitivity to the active ingredient ibuprofen or to any of the excipients; Bronchospasm, asthma, rhinitis or urticaria after taking acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs in history; Nonspecific hematopoietic disorders; Active or recurrent gastric and/or duodenal ulcer disease or gastrointestinal hemorrhages (two or more separate episodes of confirmed ulceration or bleeding); Gastrointestinal bleeding or perforation due to a history of NSAID intake; Cerebral vascular bleeding or other active bleeding; Severe renal or hepatic insufficiency; Severe heart failure (NYHA class IV); Third trimester of pregnancy; In children weighing less than 20 kg (6 years), as this dose of the drug product is not suitable for this age group due to the content of the active substance.

Marketing authorization holder: Berlin-Chemie AG Glienicker Weg 125 ;12489 Berlin, Germany;

Updated 07.2021,

Scientific information: BERLIN-CHEMIE/MENARINI POLSKA Sp. z o.o. 4 Słomińskiego St., 00-204 Warsaw, tel. 22 566 21 00

Before use, read the leaflet, which contains indications, contraindications, data on adverse reactions and dosage, and information on the use of the medicinal product, or consult your doctor or pharmacist, as any drug used inappropriately threatens your life or health.